Niche oleocanthal Oleolive focuses on extracting and commercializing oleocanthal for research, supplements, and potential therapeutics, representing a specialized product line that can be pitched to biotech labs, universities, and nutraceutical manufacturers seeking high-quality oleocanthal.

Licensing and exclusivity An exclusive license from the University of Louisiana at Monroe for oleocanthal extraction creates a defensible sourcing advantage, suggesting a sales angle around reliable supply, quality, and potential collaboration on new research applications.

Early stage traction With a revenue range of one to ten million and a small team, Oleolive is positioned as a nimble partner capable of rapid pilot programs, agile customization, and close collaboration with customers in academia and early-stage biotech companies.

Recent recognition Award from a small business research program signals credibility and potential for grant-aligned partnerships, enabling joint grant applications, co-development opportunities, and credibility when approaching larger customers.

Product diversification Beyond oleocanthal extraction, Oleolive has launched Oligen and CBD-related products, indicating appetite for portfolio expansion and cross-sell opportunities into nutraceuticals, wellness brands, and contract manufacturing for specialty supplements.